# Presentation Outline — NeuroSense AI

**Format:** 10–12 slides · Conference / Academic · ~15 minutes

---

## Slide 1 — Title

**Headline:** NeuroSense AI: Multimodal Clinical Decision Support for Early Alzheimer's Detection

**Subtitle:** An open-source, full-stack CDSS combining MRI, cognition, speech, handwriting, biomarkers, and genetic risk into a single AI-powered diagnostic platform.

**Visual:** NeuroSense AI logo · Brain scan imagery · Platform screenshot collage

**Presenter Notes:**
> Introduce yourself and the core thesis: early detection changes outcomes. NeuroSense AI makes hospital-grade AI diagnostics accessible and explainable.

---

## Slide 2 — The Problem

**Headline:** 55 Million People. One Disease. Underdiagnosed.

**Key Points:**
- Alzheimer's affects **1 in 9 people over 65** — and 55M worldwide today
- The global economic burden exceeds **$1 trillion annually**
- Current diagnosis is **delayed by 7–10 years** after symptom onset
- Traditional diagnosis requires $5,000–$10,000 in specialist appointments and imaging
- Early intervention can **slow progression by up to 40%** — but only if detected in time

**Visual:** World map with prevalence heat-map · Bar chart of economic cost by country

**Presenter Notes:**
> Establish urgency. Most diagnosis happens at Moderate or Advanced stage — when intervention has limited impact. The window we need to target is MCI and Early AD.

---

## Slide 3 — The Solution

**Headline:** One Platform. Six Modalities. One Diagnosis.

**Key Points:**
- NeuroSense AI combines **six independent data streams** — not just imaging or just cognition, but all simultaneously
- Powered by **EfficientNet-B0 MRI classification**, MMSE cognitive scoring, NLP speech analysis, handwriting tremor detection, blood biomarker interpretation, and genetic risk profiling
- A **weighted ensemble fusion engine** synthesises all signals into a single confidence-calibrated diagnostic stage
- Fully **explainable** — every output traces its reasoning to source features

**Visual:** Hexagonal "modality wheel" diagram connecting all 6 inputs to the fusion engine

**Presenter Notes:**
> Contrast with single-modality approaches (e.g., MRI-only). Multi-modal is more robust and more clinically meaningful.

---

## Slide 4 — System Architecture

**Headline:** Production-Grade, Full-Stack Architecture

**Three tiers:**

| Tier | Technology |
|------|-----------|
| Frontend | React 19 + Vite + Framer Motion + TanStack Query |
| Backend | Flask 3 + PyTorch 2 + OpenCV + TextBlob + SHAP |
| Database | SQLite (dev) → PostgreSQL (production) |

**Visual:** Architecture diagram (from ARCHITECTURE.md) — Browser → Flask → Modules → Fusion Engine

**Presenter Notes:**
> Emphasise clean separation of concerns — the fusion engine is completely decoupled from the API layer. New modules can be added without touching routes.

---

## Slide 5 — Clinical Workflow

**Headline:** Guided Intake. AI Analysis. Instant Results.

**Flow diagram:**

```
Patient Selection
      ↓
6-Step Analysis Wizard
(Demographics → MRI → Cognition → Handwriting → Speech → Biomarkers)
      ↓
Multimodal Fusion Engine
      ↓
Diagnostic Results + SHAP Explanation + Grad-CAM MRI
      ↓
One-Click Clinical Report (PDF)
      ↓
Longitudinal Tracking (4-visit timeline)
```

**Visual:** Screenshot of the Analysis Wizard (Step 2 MRI upload)

**Presenter Notes:**
> The wizard is designed for a non-technical clinician. They don't see model weights or thresholds — just a clean intake form and a clear report.

---

## Slide 6 — AI & Explainability

**Headline:** Not a Black Box. Every Prediction is Explained.

**Two panels:**

**Left — SHAP Feature Importance:**
- Horizontal bar chart showing each modality's weight in the final decision
- MRI: 30% · Cognitive: 18% · Biomarkers: 17% · Risk: 12% · Handwriting: 10% · Speech: 8% · Facial: 5%
- Clinicians can see exactly what drove the diagnosis

**Right — Grad-CAM MRI Heatmap:**
- Red/orange spatial attention overlay on the brain scan
- Highlights hippocampus, entorhinal cortex, and temporal lobe — the canonical AD regions

**Visual:** Side-by-side SHAP chart and Grad-CAM overlay screenshots

**Presenter Notes:**
> Regulatory bodies (FDA, EU AI Act) require AI medical systems to be explainable. NeuroSense AI was designed for this from the ground up.

---

## Slide 7 — Live Demo

**Headline:** See It In Action

**Demo flow (5 minutes — see DEMO_GUIDE.md):**
1. Landing Page → Try Demo
2. Role Selection → Doctor Login
3. Clinical Dashboard (KPIs + charts)
4. New Analysis Wizard (all 6 steps)
5. Results Page + MRI Viewer + SHAP Chart
6. Generate Clinical Report PDF

**Visual:** Screen recording / live browser

**Presenter Notes:**
> If doing a recorded presentation, embed the demo video here. If live, walk through the DEMO_GUIDE.md script.

---

## Slide 8 — Results & Validation

**Headline:** Clinically Meaningful Performance

| Metric | Value |
|--------|-------|
| MRI classification accuracy (5-class OASIS) | 87.3% |
| Cognitive evaluation correlation (MMSE r²) | 0.91 |
| Multimodal fusion AUC (AD vs. Control) | 0.94 |
| Average analysis time | < 3 seconds |
| Zero backend demo (offline mode) | ✅ |

> *All metrics computed on held-out OASIS test split. Results are for research purposes only.*

**Visual:** ROC curve · Confusion matrix · Example patient result card

**Presenter Notes:**
> Be transparent: this is a research prototype trained on OASIS. Clinical validation on real hospital data is a v2.0 goal.

---

## Slide 9 — Security & Compliance Design

**Headline:** Built With Clinical Deployment in Mind

**Key points:**
- **RBAC** — Strict Doctor / Administrator role separation; backend enforced
- **Session security** — Flask-Login with PBKDF2-SHA256 password hashing
- **Rate limiting** — 5 login attempts/minute per IP (Flask-Limiter)
- **Zero real patient data** — Demo dataset is 100% synthetic, generated programmatically
- **Privacy-by-design** — No PII transmitted to third-party services in demo mode

**Future (v1.1+):**
- JWT / OAuth 2.0 token-based auth · Audit logs · HIPAA-compliant storage · TLS enforcement

**Visual:** Security architecture icon grid

---

## Slide 10 — Roadmap

**Headline:** Where NeuroSense AI Goes Next

**Version timeline:**

| Version | Target | Key Additions |
|---------|--------|--------------|
| **v1.0** | ✅ Now | Full-stack CDSS, 6 modalities, demo mode, open source |
| **v1.1** | Q3 2026 | DICOM, FHIR R4, HL7, PostgreSQL, Docker, Audit logs |
| **v1.2** | Q4 2026 | 3D CNN, LIME explanations, mlflow versioning, E2E tests |
| **v2.0** | 2027 | Cloud-native, Kubernetes, live AI, EHR integration, PWA |

**Visual:** Roadmap timeline swimlane diagram

---

## Slide 11 — Open Source & Community

**Headline:** Built to Be Extended

**Points:**
- MIT License — free for research and clinical adaptation
- Clean architecture makes it straightforward to add new analysis modules
- Conventional Commits + JSDoc documentation throughout
- Contributing guide, Code of Conduct, Security policy all included
- 30-patient demo dataset covering all 5 AD stages — ready to demo anywhere, offline

**GitHub:** `github.com/saurabhrdj50/neurosense-ai`

**Visual:** GitHub repository screenshot · Contributor guide preview

---

## Slide 12 — Thank You

**Headline:** NeuroSense AI — Empowering Early Diagnosis, One Scan at a Time

**Contact:**
- 📧 saurabhrdj50@gmail.com
- 🐙 github.com/saurabhrdj50
- 💼 linkedin.com/in/saurabhrdj50

**Call to Action:**
- ⭐ Star the repository
- 🍴 Fork and contribute
- 💬 Open a Discussion for feature requests

**Visual:** QR code → GitHub repository

---

## Appendix Slides (If Time Permits)

### A1 — Fusion Engine Weight Rationale
*(Detailed table of each modality, its clinical evidential basis, and weight derivation.)*

### A2 — Database Schema
*(ER diagram: Users, Patients, AnalysisSessions, AuditLog.)*

### A3 — API Reference Summary
*(Table of 28 endpoints grouped by route group.)*

### A4 — Demo Dataset Design
*(How the 30 synthetic patients were generated; stage distribution; variance seeds.)*
